MIRAILAB BIOSCIENCE Launches NMN Supplements and Cosmetics in Singapore

MIRAILAB BIOSCIENCE Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Megumi Tanaka) has partnered with Global Ocean Distribution Pte Ltd (Headquarters: Circular Road; Director: Getty Poon) to introduce its premium supplement brand MIRAI LAB, which features β-Nicotinamide Mononucleotide (β-NMN), to the Singapore market.…

Read MoreMIRAILAB BIOSCIENCE Launches NMN Supplements and Cosmetics in Singapore

MedLumics Completes FIM Study, to Present AblaView® PFA Results at AF Symposium 2025

Peter Hinchliffe, CEO of MedLumics, stated, “This marks a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system, utilizing Pulsed Field Ablation (PFA) and Optical Coherence Reflectometry (OCR) to monitor and confirm ablation success in real-time under direct…

Read MoreMedLumics Completes FIM Study, to Present AblaView® PFA Results at AF Symposium 2025

Weave Survey Shows How Patients Use Online Resources in Healthcare Decisions

A recent survey commissioned by Weave (NYSE: WEAV) sheds light on how patients across different generations are increasingly turning to the internet for health-related information and how this influences their interactions with healthcare providers. The study, conducted among 1,000 U.S.-based…

Read MoreWeave Survey Shows How Patients Use Online Resources in Healthcare Decisions

Sorriso Pharmaceuticals Reports Positive Phase 1b Results for SOR102 in Ulcerative Colitis

Sorriso Pharmaceuticals, a biopharmaceutical company focused on developing novel oral antibodies for immune-mediated diseases, today announced positive results from its Phase 1b clinical trial of SOR102. This oral, dual-acting biologic targets TNFα and IL-23 and was tested in patients with…

Read MoreSorriso Pharmaceuticals Reports Positive Phase 1b Results for SOR102 in Ulcerative Colitis

FlexIt Launches FlexTogether™, Revolutionizing Fitness and Global Connectivity

FlexIt, a leader in virtual fitness and wellness, is excited to announce the launch of FlexTogether™, a groundbreaking platform designed to connect individuals globally through innovative wellness experiences. This new initiative features FlexIt’s proprietary AI Class Creator™ Technology, which enhances…

Read MoreFlexIt Launches FlexTogether™, Revolutionizing Fitness and Global Connectivity

Jacques Gilbert Named Chief Strategy and Business Development Officer at Topcon Healthcare

Topcon Healthcare, Inc., a leading provider of medical devices and digital healthcare solutions, is excited to announce the appointment of Jacques Gilbert as Chief Strategy and Business Development Officer. In this key role, Jacques will spearhead the development and execution…

Read MoreJacques Gilbert Named Chief Strategy and Business Development Officer at Topcon Healthcare

LimmaTech’s Staphylococcus aureus Vaccine Candidate Gets FDA Fast Track Status

LimmaTech Biologics AG, a clinical-stage biotech company focused on developing vaccines for life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its multivalent toxoid vaccine candidate, LBT-SA7. The vaccine is designed…

Read MoreLimmaTech’s Staphylococcus aureus Vaccine Candidate Gets FDA Fast Track Status

Vivani Medical Launches First Human Trial of GLP-1 Implant for Obesity in Australia

Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™, at two centers in Australia. The trial aims to evaluate…

Read MoreVivani Medical Launches First Human Trial of GLP-1 Implant for Obesity in Australia